RxDoctor Payments Data

Brett Duncan, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · Omaha, NENPI 1720309917

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $4,319 of the $6,900 with a category attached, or 62.6%. 6 manufacturers reported payments, led by Atricure, Inc. at 37.5% of the total. 2025 is the largest year on record at $3,948, more than ten times the $271 reported in 2020.

$6,900in general payments, 2019–2025

Across 44 payments — averaging $156.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$3K
  • Medtronic$2K
  • Artivion, Inc.$1K
  • Edwards Lifesciences$715
  • Abbott$332
  • Conetic Solutions, Inc.$108
$51,892in research payments, 2019–2025

Across 5 payments — averaging $10,378 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Atricure, Inc.$52K

What the payments were for

  • Travel & lodging$4,31963%
  • Food & beverage$2,40135%
  • Education$1803%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Atricure, Inc.17$2,587
Medtronic10$1,699
Artivion, Inc.6$1,458
Edwards Lifesciences7$715
Abbott3$332
Conetic Solutions, Inc.1$108

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,900 in reported general payments places this provider in the 55th percentile of 29 thoracic surgery (cardiothoracic vascular surgery) providers in Nebraska.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Nebraska

Medicare billing

Part B allowed, 2024
$150,041
Medicare patients
129
Services billed
288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine12$145
Ezetimibe11$71
Amiodarone Hcl12$65
ClopidogrelClopidogrel Bisulfate11$51
Pantoprazole Sodium11$47

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →